IONS Ionis Pharmaceuticals, Inc. - Common Stock
IONS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
IONS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
IONS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 8 25.8%
- 매수 17 54.8%
- 보유 6 19.4%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
21 명의 애널리스트 · 2026-08-18실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.69 | $-1.09 | 0.40% |
| 2026년 3월 31일 | $-0.56 | $-0.93 | 0.37% |
| 2025년 12월 31일 | $-1.41 | $-1.35 | -0.06% |
| 2025년 9월 30일 | $-0.80 | $-1.26 | 0.46% |
| 2025년 6월 30일 | $0.70 | $-0.44 | 1.1% |
| 2025년 3월 31일 | $-0.93 | $-1.14 | 0.21% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| PCVX | $6.05B | -8.2 | — | — | -26.6% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | $508M | $347M | $284M | $214M | |
| Cost of Revenue | $16M | $11M | $9M | $14M | $11M | $12M | $4M | $2M | $0 | $0 | · | · | |
| R&D Expense | $916M | $902M | $900M | · | $638M | $531M | $462M | $412M | $372M | $340M | $320M | $239M | |
| SG&A Expense | $394M | $267M | $233M | $150M | $186M | $354M | $287M | $245M | $108M | $49M | $37M | $20M | |
| Operating Expenses | $1.33B | $1.18B | $1.14B | $998M | $841M | $901M | $757M | $661M | $483M | $393M | $359M | $262M | |
| Operating Income | $-382M | $-475M | $-354M | $-410M | $-30M | $-172M | $366M | $-61M | $31M | $-20M | $-76M | $-48M | |
| Interest Expense | $17M | $17M | $13M | $8M | $9M | $10M | $12M | $45M | $45M | $39M | $37M | $22M | |
| Other Non-op | $-15M | $1M | $14M | $-7M | $-10M | $-62.0K | $-686.0K | $-182.0K | $-4M | $0 | · | · | |
| Pretax Income | $-380M | $-460M | $-334M | $-258M | $-29M | $-135M | $339M | $-76M | $-17M | $-57M | $-88M | $-54M | |
| Income Tax | $2M | $-6M | $32M | $12M | $-551.0K | $345M | $52M | $-291M | $-6M | $3M | $372.0K | $-15M | |
| Net Income | $-381M | $-454M | $-366M | $-270M | $-29M | $-444M | $278M | $274M | $346.0K | $-60M | $-88M | $-39M | |
| EPS (Basic) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.18 | $2.00 | $2.09 | $0.15 | $-0.50 | $-0.74 | · | |
| EPS (Diluted) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.18 | $1.90 | $2.07 | $0.15 | $-0.50 | $-0.74 | · | |
| Shares (Basic) | 160,010,000 | 149,514,000 | 143,190,000 | 141,848,000 | 141,021,000 | 139,612,000 | 139,998,000 | 132,320,000 | 124,016,000 | 120,933,000 | 119,719,000 | · | |
| Shares (Diluted) | 160,010,000 | 149,514,000 | 143,190,000 | 141,848,000 | 141,021,000 | 139,612,000 | 153,164,000 | 134,056,000 | 126,098,000 | 120,933,000 | 119,719,000 | · | |
| EBITDA | $-382M | $-475M | $-354M | $-410M | $-30M | $-172M | $366M | $-61M | $25M | $-46M | $-76M | $-48M |
대차대조표 24
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $372M | $242M | $399M | $276M | $869M | $398M | $683M | $279M | $130M | $85M | $129M | $143M | |
| Short-term Investments | $2.31B | $2.06B | $1.93B | $1.71B | $1.25B | · | · | · | · | · | · | · | |
| Inventory | $10M | $13M | $7M | $22M | $25M | $22M | $18M | $9M | $10M | · | · | · | |
| Other Current Assets | $237M | $218M | $205M | $168M | $143M | $140M | $140M | $102M | $73M | $17M | $15M | $16M | |
| Current Assets | $2.99B | $2.62B | $2.64B | $2.20B | $2.35B | $2.13B | $2.72B | $2.21B | $1.17B | $798M | $837M | $837M | |
| PP&E (Net) | $123M | $94M | $71M | $74M | $178M | $181M | $154M | $132M | $122M | $93M | $90M | $89M | |
| Accum. Depreciation | $109M | $106M | $97M | $88M | $103M | $87M | $74M | $61M | $88M | $80M | $73M | $66M | |
| Intangibles | · | · | · | · | $29M | $28M | $26M | $24M | $22M | $20M | · | · | |
| Other Non-current Assets | $172M | $127M | $105M | $75M | $71M | $50M | $28M | $13M | $10M | $1M | · | · | |
| Total Assets | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B | $3.23B | $2.67B | $1.32B | $912M | $948M | $956M | |
| Accounts Payable | $28M | $43M | $26M | $18M | $12M | $17M | $16M | $29M | $25M | $21M | $28M | $18M | |
| Accrued Liabilities | $106M | $108M | $148M | $140M | $89M | $90M | $67M | $48M | $67M | $36M | $28M | $30M | |
| Current Liabilities | $782M | $309M | $448M | $312M | $241M | $599M | $273M | $280M | $244M | $134M | $149M | $115M | |
| Capital Leases | $262M | $162M | $171M | $179M | $19M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $28M | $52M | $42M | $16M | $7M | · | · | · | · | · | · | · | |
| Total Liabilities | $3.03B | $2.42B | $2.60B | $1.96B | $1.84B | $1.65B | $1.55B | $1.48B | $957M | $813M | $747M | $698M | |
| Long-term Debt | $1.81B | $1.25B | $1.31B | $1.19B | · | · | · | · | · | · | · | · | |
| Total Debt | $1.76B | $1.20B | $1.24B | $1.18B | · | · | · | · | · | · | · | · | |
| Common Stock | $163.0K | $158.0K | $144.0K | $142.0K | $141.0K | $140.0K | $140.0K | $138.0K | $125.0K | $122.0K | $120.0K | $118.0K | |
| Retained Earnings | $-2.63B | $-2.25B | $-1.80B | $-1.43B | $-1.16B | $-1.13B | $-708M | $-967M | $-1.24B | $-1.18B | $-1.09B | $-1.01B | |
| AOCI | $-25M | $-31M | $-33M | $-57M | $-33M | $-21M | $-25M | $-32M | $-32M | $-30M | $-14M | $40M | |
| Stockholders' Equity | $489M | $588M | $387M | $573M | $772M | $743M | $1.47B | $1.05B | $281M | $100M | $201M | $258M | |
| Liabilities + Equity | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B | $3.23B | $2.67B | $1.32B | $912M | $948M | $956M | |
| Shares Outstanding | 163,304,875 | 157,908,815 | 144,340,526 | 142,057,736 | 141,210,015 | 140,365,594 | 140,339,615 | 137,928,828 | 124,976,373 | 121,636,273 | 120,351,480 | 118,442,726 |
현금 흐름 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $134M | $130M | $106M | $100M | $121M | $230M | $147M | $131M | $86M | $72M | $59M | $31M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $342M | $904.0K | $-291M | $0 | $0 | $0 | $-11M | |
| Amort. of Intangibles | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Operating Cash Flow | $-269M | $-501M | $-308M | $-274M | $31M | $36M | $346M | $603M | $174M | $-112M | $21M | $6M | |
| CapEx | $51M | $45M | $24M | $16M | $12M | $35M | $31M | $14M | $35M | $7M | $8M | $8M | |
| Investing Cash Flow | $-278M | $-134M | $-214M | $-263M | $195M | $274M | $-41M | $-930M | $-358M | $57M | $-60M | · | |
| Stock Issued | $0 | $489M | $0 | $0 | · | $0 | $0 | $448M | $72M | $0 | $0 | $0 | |
| Stock Repurchased | · | · | · | $0 | $0 | $91M | $34M | $0 | $0 | · | · | · | |
| Net Stock Activity | $0 | $489M | · | $0 | $0 | $-91M | $-34M | · | $72M | · | $0 | $0 | |
| Financing Cash Flow | $676M | $478M | $644M | $-55M | $246M | $-597M | $100M | $476M | $229M | $11M | $25M | · | |
| Net Change in Cash | $130M | $-157M | $123M | $-593M | $472M | $-286M | $404M | $149M | $45M | $-44M | $-14M | · | |
| Taxes Paid | $-639.0K | $-6M | $48M | $5M | · | $26M | $9M | $0 | $0 | · | · | · | |
| Free Cash Flow | $-320M | $-546M | $-331M | $-290M | $19M | $772.0K | $315M | $589M | $139M | $-119M | $13M | $-1M | |
| Levered FCF | $-337M | $-563M | $-345M | $-299M | $10M | $-128M | $272M | $716M | $106M | $-159M | $-23M | $-17M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | 4.8% | -13.4% | -26.7% | -22.3% | |
| Net Margin | · | · | · | · | · | · | · | · | -1.2% | -25.0% | -31.1% | -18.2% | |
| Pretax Margin | · | · | · | · | · | · | · | · | -4.6% | -24.1% | -31.0% | -25.4% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | 4.8% | -13.4% | -26.7% | -22.3% | |
| ROA | -11.7% | -15.2% | -13.3% | -10.5% | -1.1% | -16.1% | 10.0% | 13.7% | -0.53% | -9.3% | -9.2% | -4.3% | |
| ROE | -68.1% | -71.9% | -104.3% | -40.1% | -3.8% | -39.0% | 23.4% | 41.2% | -2.8% | -57.6% | -38.5% | -12.3% | |
| ROIC | -17.1% | -26.0% | -23.8% | -24.5% | -3.8% | -58.4% | 21.8% | 16.5% | 5.5% | -48.1% | -37.9% | -13.3% |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 8.5 | 5.9 | 7.1 | 9.7 | 3.7 | 10.0 | 7.9 | 5.2 | 6.0 | 5.6 | 7.3 | |
| Quick Ratio | 3.4 | 7.4 | 5.2 | 6.4 | 3.6 | 0.7 | 2.5 | 1.0 | 0.6 | 0.6 | 0.9 | 1.2 | |
| Debt / Equity | 3.6 | 2.0 | 3.2 | 2.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 2.7 | 2.0 | 3.2 | 2.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | -22.1 | -28.0 | -27.9 | -50.5 | -3.2 | -3.8 | 7.5 | -1.4 | 0.5 | -1.2 | -2.1 | -2.1 |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | 0.5 | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | 1.4 | 1.1 | 0.4 | 0.6 | 0.5 | 0.6 | 0.3 | 0.2 | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $944M | $705M | $788M | $587M | $810M | $729M | $1.12B | $600M | $508M | $347M | $284M | $214M | |
| Net Income TTM | $-381M | $-454M | $-366M | $-270M | $-29M | $-444M | $278M | $274M | $346.0K | $-60M | $-88M | $-39M | |
| Market Cap | $12.92B | $5.52B | $7.30B | $5.37B | $4.30B | $7.94B | $8.48B | $7.46B | $6.29B | $5.82B | $7.45B | $7.31B | |
| Enterprise Value | $12.00B | $4.43B | $6.21B | $4.55B | · | · | · | · | · | · | · | · | |
| P/E | -33.2 | -11.5 | -19.8 | -19.9 | -152.2 | -17.8 | 31.8 | 26.1 | 335.3 | -95.7 | -83.7 | -176.4 | |
| P/S | 13.7 | 7.8 | 9.3 | 9.1 | 5.3 | 10.9 | 7.6 | 12.4 | 12.4 | 16.8 | 26.3 | 34.1 | |
| P/B | 26.4 | 9.2 | 18.9 | 9.4 | 5.6 | 9.4 | 5.8 | 7.1 | 19.0 | 58.4 | 37.1 | 28.4 | |
| P / Tangible Book | 26.4 | 9.4 | 18.9 | 9.4 | 5.8 | 11.1 | · | · | · | · | · | · | |
| P / Cash Flow | -48.1 | -11.0 | -23.7 | -19.6 | 139.5 | 221.1 | 24.5 | 12.4 | 36.1 | -51.9 | 352.8 | 1163.5 | |
| P / FCF | -40.4 | -10.1 | -22.0 | -18.5 | 228.0 | 10280.1 | 26.9 | 12.7 | 45.1 | -48.8 | 554.9 | -5930.8 | |
| EV / EBITDA | -31.4 | -9.3 | -17.6 | -11.1 | · | · | · | · | · | · | · | · | |
| EV / FCF | -37.5 | -8.1 | -18.7 | -15.7 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 12.7 | 6.3 | 7.9 | 7.8 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -3.0% | -8.7% | -5.1% | -5.0% | -0.66% | -5.6% | 3.1% | 3.8% | 0.30% | -1.1% | -1.2% | -0.57% |
손익계산서 15
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $268M | $246M | $203M | $157M | $452M | $132M | $227M | $134M | $225M | $119M | $325M | $144M | $188M | $131M | $152M | $160M | |
| Cost of Revenue | $3M | $3M | $8M | $2M | $4M | $1M | $4M | $1M | $4M | $2M | $3M | $2M | $3M | $1M | $4M | $2M | |
| SG&A Expense | $150M | $150M | $130M | $97M | $91M | $76M | $88M | $62M | $65M | $53M | $71M | $70M | $46M | $46M | $48M | $34M | |
| Operating Expenses | $370M | $364M | $418M | $317M | $312M | $278M | $337M | $282M | $291M | $269M | $331M | $287M | $279M | $245M | $360M | $219M | |
| Operating Income | $-102M | $-117M | $-214M | $-160M | $140M | $-147M | $-111M | $-149M | $-66M | $-150M | $-6M | $-143M | $-90M | $-114M | $-208M | $-59M | |
| Interest Expense | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $2M | $2M | $2M | $2M | |
| Other Non-op | $987.0K | $-456.0K | $-16M | $363.0K | $102.0K | $465.0K | $302.0K | $142.0K | $610.0K | $277.0K | $235.0K | $2M | $11M | $230.0K | $123.0K | $5M | |
| Pretax Income | $-113M | $-92M | $-228M | $-128M | $124M | $-147M | $-107M | $-144M | $-66M | $-143M | $-3M | $-141M | $-77M | $-113M | $-44M | $-47M | |
| Income Tax | $1M | $218.0K | $1M | $213.0K | $-20.0K | $116.0K | $-3M | $-4M | $64.0K | $75.0K | $6M | $7M | $8M | $11M | $8M | $283.0K | |
| Net Income | $-115M | $-93M | $-229M | $-129M | $124M | $-147M | $-104M | $-140M | $-66M | $-143M | $-9M | $-147M | $-85M | $-124M | $-52M | $-47M | |
| EPS (Basic) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.78 | $-0.93 | $-0.66 | $-0.95 | $-0.45 | $-0.98 | $-0.06 | $-1.03 | $-0.60 | $-0.87 | $-0.37 | $-0.33 | |
| EPS (Diluted) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.70 | $-0.93 | $-0.66 | $-0.95 | $-0.45 | $-0.98 | $-0.06 | $-1.03 | $-0.60 | $-0.87 | $-0.37 | $-0.33 | |
| Shares (Basic) | 165,419,000 | 164,874,000 | -317,627,000 | 159,765,000 | 159,137,000 | 158,735,000 | -290,575,000 | 148,593,000 | 145,958,000 | 145,538,000 | -285,960,000 | 143,317,000 | 143,098,000 | 142,735,000 | -283,495,000 | 141,950,000 | |
| Shares (Diluted) | 165,419,000 | 164,874,000 | -340,821,000 | 159,765,000 | 182,331,000 | 158,735,000 | -290,575,000 | 148,593,000 | 145,958,000 | 145,538,000 | -285,960,000 | 143,317,000 | 143,098,000 | 142,735,000 | -283,495,000 | 141,950,000 | |
| EBITDA | $-102M | $-117M | · | $-160M | $140M | $-147M | · | $-149M | $-66M | $-150M | · | $-143M | $-90M | $-114M | · | $-59M |
대차대조표 23
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $350M | $173M | $372M | $338M | $297M | $264M | $242M | $335M | $294M | $349M | · | $352M | $425M | $309M | · | $315M | |
| Short-term Investments | $1.70B | $1.75B | $2.31B | $1.90B | $1.99B | $1.88B | $2.06B | $2.15B | $1.78B | $1.86B | · | $1.88B | $1.96B | $2.04B | · | $1.67B | |
| Inventory | $51M | $6M | $10M | $10M | $8M | $12M | $13M | $28M | $29M | $30M | · | $26M | $26M | $22M | · | $21M | |
| Other Current Assets | $327M | $306M | $237M | $244M | $226M | $223M | $218M | $184M | $195M | $174M | · | $181M | $178M | $160M | · | $143M | |
| Current Assets | $2.49B | $2.94B | $2.99B | $2.52B | $2.58B | $2.42B | $2.62B | $2.71B | $2.33B | $2.42B | · | $2.58B | $2.62B | $2.54B | · | $2.15B | |
| PP&E (Net) | $155M | $142M | $123M | $106M | $112M | $103M | $94M | $83M | $76M | $73M | · | $71M | $92M | $85M | · | $181M | |
| Accum. Depreciation | · | · | $109M | · | · | · | $106M | · | · | · | · | · | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $117M | $136M | $172M | $166M | $132M | $132M | $127M | $120M | $119M | $106M | · | $104M | $86M | $78M | · | $59M | |
| Total Assets | $2.99B | $3.45B | $3.52B | $3.03B | $2.99B | $2.81B | $3.00B | $3.08B | $2.69B | $2.76B | · | $2.93B | $2.97B | $2.89B | · | $2.42B | |
| Accounts Payable | $48M | $26M | $28M | $14M | $23M | $17M | $43M | $9M | $9M | $13M | · | $6M | $24M | $10M | · | $21M | |
| Accrued Liabilities | $116M | $127M | $106M | $99M | $99M | $103M | $108M | $124M | $114M | $106M | · | $119M | $105M | $113M | · | $128M | |
| Current Liabilities | $316M | $717M | $782M | $903M | $897M | $250M | $309M | $305M | $306M | $328M | · | $404M | $288M | $259M | · | $283M | |
| Capital Leases | $262M | $259M | $262M | $263M | $164M | $159M | $162M | $168M | $166M | $169M | · | $173M | $175M | $177M | · | · | |
| Other Non-current Liabilities | $28M | $28M | · | $29M | $59M | $56M | · | $42M | $42M | $42M | · | $49M | $16M | $7M | · | · | |
| Total Liabilities | $2.55B | $2.96B | $3.03B | $2.42B | $2.35B | $2.34B | $2.42B | $2.42B | $2.43B | $2.47B | · | $2.62B | $2.54B | $2.40B | · | $1.83B | |
| Long-term Debt | · | · | $1.81B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $166.0K | $166.0K | $163.0K | $161.0K | $159.0K | $159.0K | $158.0K | $158.0K | $146.0K | $146.0K | · | $143.0K | $143.0K | $143.0K | · | $142.0K | |
| Retained Earnings | $-2.84B | $-2.72B | $-2.63B | $-2.40B | $-2.27B | $-2.40B | $-2.25B | $-2.15B | $-2.00B | $-1.94B | · | $-1.79B | $-1.64B | $-1.55B | · | $-1.38B | |
| AOCI | $-34M | $-31M | $-25M | $-26M | $-28M | $-29M | $-31M | $-24M | $-35M | $-35M | · | $-46M | $-51M | $-49M | · | $-63M | |
| Stockholders' Equity | $440M | $491M | $489M | $618M | $632M | $476M | $588M | $662M | $264M | $297M | $387M | $315M | $428M | $487M | $573M | $594M | |
| Liabilities + Equity | $2.99B | $3.45B | $3.52B | $3.03B | $2.99B | $2.81B | $3.00B | $3.08B | $2.69B | $2.76B | · | $2.93B | $2.97B | $2.89B | · | $2.42B | |
| Shares Outstanding | 165,636,792 | 165,902,064 | 163,304,875 | 161,137,930 | 159,196,782 | 159,041,259 | 157,908,815 | 157,813,136 | 146,025,246 | 145,844,719 | · | 143,393,493 | 143,167,414 | 143,022,539 | · | 142,017,411 |
현금 흐름 11
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $46M | $43M | $43M | $31M | $30M | $30M | $36M | $32M | $31M | $31M | $26M | $26M | $27M | $27M | $26M | $24M | |
| Amort. of Intangibles | $700.0K | $661.0K | $638.0K | $621.0K | $598.0K | $582.0K | $459.0K | $617.0K | $621.0K | $639.0K | $655.0K | $660.0K | $637.0K | $607.0K | $610.0K | $608.0K | |
| Operating Cash Flow | $566M | $-793M | $-138M | $-131M | $151M | $-151M | $-116M | $-115M | $-120M | $-150M | $33M | $-109M | $-97M | $-134M | $-200M | $-24M | |
| CapEx | $16M | $22M | $21M | $5M | $12M | $13M | $25M | $9M | $6M | $4M | $-819.0K | $2M | $12M | $10M | $4M | $6M | |
| Investing Cash Flow | $23M | $537M | $-420M | $91M | $-120M | $170M | $68M | $-341M | $62M | $76M | $-27M | $69M | $70M | $-326M | $212M | $-184M | |
| Stock Issued | · | · | $0 | · | · | · | $27.0K | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $-412M | $57M | $591M | $81M | $1M | $2M | $-44M | $496M | $3M | $24M | $41M | $-32M | $144M | $492M | $-51M | $2M | |
| Net Change in Cash | $177M | $-199M | $34M | $41M | $33M | $22M | $-93M | $41M | $-55M | $-50M | $47M | $-73M | $116M | $33M | $-39M | $-207M | |
| Taxes Paid | $1M | $-8.0K | $22.0K | $-278.0K | $17.0K | $-400.0K | $-8M | $80.0K | $2M | $13.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | $-815M | · | · | · | $-163M | · | · | · | $-154M | · | · | · | $-144M | · | · | |
| Levered FCF | · | $-820M | · | · | · | $-167M | · | · | · | $-159M | · | · | · | $-146M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -38.2% | -47.7% | · | -102.2% | 30.9% | -111.6% | · | -111.1% | -29.3% | -125.1% | · | -99.4% | -47.9% | -87.5% | · | -37.0% | |
| Net Margin | -42.8% | -37.6% | · | -82.1% | 27.3% | -111.6% | · | -105.0% | -29.4% | -119.5% | · | -102.2% | -45.3% | -95.2% | · | -29.4% | |
| Pretax Margin | -42.3% | -37.5% | · | -81.9% | 27.3% | -111.6% | · | -107.7% | -29.4% | -119.4% | · | -97.6% | -41.1% | -86.5% | · | -29.2% | |
| EBITDA Margin | -38.2% | -47.7% | · | -102.2% | 30.9% | -111.6% | · | -111.1% | -29.3% | -125.1% | · | -99.4% | -47.9% | -87.5% | · | -37.0% | |
| ROA | -3.8% | -2.9% | · | -4.2% | 4.3% | -5.3% | · | -4.7% | -2.3% | -5.1% | · | -5.5% | -3.1% | -4.6% | · | -1.9% | |
| ROE | -21.4% | -19.1% | · | -20.1% | 27.6% | -38.0% | · | -28.7% | -19.1% | -36.5% | · | -32.4% | -16.2% | -20.8% | · | -8.3% | |
| ROIC | -23.5% | -23.9% | · | -26.0% | 22.1% | -30.9% | · | -21.9% | -25.1% | -50.4% | · | -47.5% | -23.2% | -25.8% | · | -10.0% |
유동성 및 지급능력 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 4.1 | · | 2.8 | 2.9 | 9.7 | · | 8.9 | 7.6 | 7.4 | · | 6.4 | 9.1 | 9.8 | · | 7.6 | |
| Quick Ratio | 6.5 | 2.7 | · | 2.5 | 2.6 | 8.6 | · | 8.2 | 6.8 | 6.7 | · | 5.5 | 8.3 | 9.1 | · | 7.0 | |
| Interest Coverage | -22.2 | -22.8 | · | -38.0 | 34.0 | -35.7 | · | -35.7 | -14.7 | -36.0 | · | -34.1 | -39.4 | -71.0 | · | -27.7 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.3 | · | 0.1 | 0.2 | 0.1 | · | 0.0 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $874M | $1.06B | · | $967M | $944M | $717M | · | $803M | $813M | $777M | · | $615M | $631M | $576M | · | $875M | |
| Net Income TTM | $-565M | $-327M | · | $-256M | $-268M | $-458M | · | $-359M | $-366M | $-385M | · | $-409M | $-309M | $-329M | · | $7M | |
| Market Cap | $13.13B | $12.46B | · | $10.54B | $6.29B | $4.80B | · | $6.32B | $6.96B | $6.32B | · | $6.50B | $5.87B | $5.11B | · | $6.28B | |
| P/E | -22.9 | -36.3 | · | -38.7 | -21.5 | -10.1 | · | -16.4 | -18.9 | -16.2 | · | -15.8 | -18.9 | -15.5 | · | -368.6 | |
| P/S | 15.0 | 11.8 | · | 10.9 | 6.7 | 6.7 | · | 7.9 | 8.6 | 8.1 | · | 10.6 | 9.3 | 8.9 | · | 7.2 | |
| P/B | 29.9 | 25.4 | · | 17.1 | 10.0 | 10.1 | · | 9.5 | 26.4 | 21.3 | · | 20.6 | 13.7 | 10.5 | · | 10.6 | |
| P / Tangible Book | 29.9 | 25.4 | · | 17.1 | 10.0 | 10.1 | · | 9.5 | 26.4 | 21.3 | · | 20.6 | 13.7 | 10.5 | · | 11.1 | |
| P / Cash Flow | · | -15.7 | · | · | · | -31.8 | · | · | · | -42.2 | · | · | · | -38.1 | · | · | |
| P / FCF | · | -15.3 | · | · | · | -29.4 | · | · | · | -40.9 | · | · | · | -35.4 | · | · | |
| Earnings Yield | -4.4% | -2.8% | · | -2.6% | -4.7% | -9.9% | · | -6.1% | -5.3% | -6.2% | · | -6.3% | -5.3% | -6.5% | · | -0.27% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 순이익 | $-381M | $-454M | $-366M | $-270M | $-29M |
| 희석 EPS | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 3.6 | 2.0 | 3.2 | 2.1 | — |
| 유동비율 | 3.8 | 8.5 | 5.9 | 7.1 | 9.7 |
| 당좌 비율 | 3.4 | 7.4 | 5.2 | 6.4 | 3.6 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-320M | $-546M | $-331M | $-290M | $19M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 575개의 제출자 · $10.8B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 80 (-4 이전 분기 대비) | 40 (-25 이전 분기 대비) | 199 (+17 이전 분기 대비) | 156 (+3 이전 분기 대비) | +28.2M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Capital World Investors | $1,718,152,930 | 21,669,226 | 15.90% | 주식 |
| FMR LLC | $1,062,239,646 | 13,396,893 | 9.83% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $623,182,054 | 7,859,529 | 5.77% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $571,799,597 | 7,211,497 | 5.29% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $558,240,214 | 7,040,487 | 5.17% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $495,748,197 | 6,252,342 | 4.59% | 주식 |
| STATE STREET CORP | $343,710,098 | 4,334,848 | 3.18% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $260,920,005 | 3,157,327 | 2.41% | 주식 |
| TWO SIGMA ADVISERS, LP | $241,452,501 | 3,052,111 | 2.23% | 주식 |
| Artisan Partners Limited Partnership | $209,327,536 | 2,640,024 | 1.94% | 주식 |
| Tweedy, Browne Co LLC | $180,805,859 | 2,280,311 | 1.67% | 주식 |
| Deep Track Capital, LP | $174,438,000 | 2,200,000 | 1.61% | 주식 |
| BAKER BROS. ADVISORS LP | $162,364,274 | 2,047,727 | 1.50% | 주식 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $156,967,955 | 1,979,669 | 1.45% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $154,383,816 | 1,947,076 | 1.43% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $127,260,529 | 1,605,001 | 1.18% | 주식 |
| Pictet Asset Management Holding SA | $126,981,913 | 1,596,998 | 1.18% | 주식 |
| BARCLAYS PLC | $125,150,305 | 1,578,387 | 1.16% | 주식 |
| GOLDMAN SACHS GROUP INC | $117,215,755 | 1,478,317 | 1.08% | 주식 |
| Polar Capital Holdings Plc | $115,289,325 | 1,454,021 | 1.07% | 주식 |
| Alyeska Investment Group, L.P. | $112,426,560 | 1,417,916 | 1.04% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $103,108,716 | 1,300,400 | 0.95% | 콜 옵션 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $103,108,000 | 1,300,392 | 0.95% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $84,114,400 | 1,060,845 | 0.78% | 주식 |
| GROUPAMA ASSET MANAGMENT | $75,195,315 | 937,083 | 0.70% | 주식 |
| Capital International Investors | $65,316,248 | 823,764 | 0.60% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65,184,309 | 822,100 | 0.60% | 풋 옵션 |
| Davern Capital Partners, LP | $63,329,637 | 798,709 | 0.59% | 주식 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $62,422,083 | 787,263 | 0.58% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $54,253,072 | 684,236 | 0.50% | 주식 |
| Eversept Partners, LP | $52,702,794 | 664,684 | 0.49% | 주식 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $51,970,948 | 655,454 | 0.48% | 주식 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $51,370,722 | 647,884 | 0.48% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $50,113,500 | 632,028 | 0.46% | 주식 |
| Caption Management, LLC | $49,952,700 | 630,000 | 0.46% | 콜 옵션 |
| NEUBERGER BERMAN GROUP LLC | $46,951,653 | 592,151 | 0.43% | 주식 |
| EVENTIDE ASSET MANAGEMENT, LLC | $45,591,750 | 575,000 | 0.42% | 주식 |
| PERCEPTIVE ADVISORS LLC | $44,878,140 | 566,000 | 0.42% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $44,355,936 | 559,414 | 0.41% | 주식 |
| JANE STREET GROUP, LLC | $44,045,595 | 555,500 | 0.41% | 콜 옵션 |
| JANE STREET GROUP, LLC | $43,070,328 | 543,200 | 0.40% | 풋 옵션 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $41,414,514 | 522,317 | 0.38% | 주식 |
| BOONE CAPITAL MANAGEMENT LLC | $41,228,976 | 519,977 | 0.38% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $39,648,965 | 500,050 | 0.37% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $36,049,119 | 454,649 | 0.33% | 주식 |
| Candriam S.C.A. | $35,251,607 | 445,019 | 0.33% | 주식 |
| FIRST TRUST ADVISORS LP | $33,872,360 | 427,197 | 0.31% | 주식 |
| PINNACLE ASSOCIATES LTD | $33,282,136 | 419,752 | 0.31% | 주식 |
| BANK OF AMERICA CORP /DE/ | $32,643,138 | 411,693 | 0.30% | 주식 |
| NOMURA HOLDINGS INC | $31,889,804 | 402,192 | 0.30% | 주식 |
| Ikarian Capital, LLC | $31,716,000 | 400,000 | 0.29% | 콜 옵션 |
| CITADEL ADVISORS LLC | $30,645,585 | 386,500 | 0.28% | 풋 옵션 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $28,771,090 | 362,859 | 0.27% | 주식 |
| BlackRock, Inc. | $28,184,582 | 355,462 | 0.26% | 주식 |
| Caption Management, LLC | $27,426,411 | 345,900 | 0.25% | 풋 옵션 |
| TD Asset Management Inc | $27,002,051 | 340,548 | 0.25% | 주식 |
| Freestone Grove Partners LP | $26,955,983 | 339,967 | 0.25% | 주식 |
| AXA Investment Managers S.A. | $26,590,024 | 406,451 | 0.25% | 주식 |
| Qube Research & Technologies Ltd | $26,479,054 | 333,952 | 0.25% | 주식 |
| Capital Research Global Investors | $26,319,205 | 331,936 | 0.24% | 주식 |
| CAPITAL FUND MANAGEMENT S.A. | $26,130,336 | 329,554 | 0.24% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $25,564,391 | 340,450 | 0.24% | 주식 |
| Carmignac Gestion | $25,452,090 | 321,000 | 0.24% | 주식 |
| Privium Fund Management B.V. | $25,366,774 | 319,924 | 0.23% | 주식 |
| Swiss National Bank | $24,976,350 | 315,000 | 0.23% | 주식 |
| ARK Investment Management LLC | $23,848,064 | 300,770 | 0.22% | 주식 |
| Integral Health Asset Management, LLC | $23,787,000 | 300,000 | 0.22% | 콜 옵션 |
| Ikarian Capital, LLC | $23,787,000 | 300,000 | 0.22% | 풋 옵션 |
| MILLENNIUM MANAGEMENT LLC | $22,904,661 | 288,872 | 0.21% | 주식 |
| DAVENPORT & Co LLC | $22,515,188 | 283,960 | 0.21% | 주식 |
| Aberdeen Group plc | $21,995,046 | 277,400 | 0.20% | 주식 |
| California Public Employees Retirement System | $21,475,141 | 270,843 | 0.20% | 주식 |
| TimesSquare Capital Management, LLC | $20,700,361 | 275,674 | 0.19% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $20,417,175 | 257,500 | 0.19% | 콜 옵션 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $19,918,837 | 251,215 | 0.18% | 주식 |
| CITADEL ADVISORS LLC | $18,709,189 | 235,959 | 0.17% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $18,514,136 | 233,499 | 0.17% | 주식 |
| CITADEL ADVISORS LLC | $18,434,925 | 232,500 | 0.17% | 콜 옵션 |
| Orion Investment Co | $17,470,362 | 220,335 | 0.16% | 주식 |
| Life Cycle Investment Partners Ltd | $17,435,554 | 219,896 | 0.16% | 주식 |
| ALGERT GLOBAL LLC | $16,401,374 | 206,853 | 0.15% | 주식 |
| Corient Private Wealth LP | $15,603,561 | 196,791 | 0.14% | 주식 |
| Eagle Health Investments LP | $15,428,010 | 194,577 | 0.14% | 주식 |
| SECTOR GAMMA AS | $15,022,918 | 189,468 | 0.14% | 주식 |
| Polymer Capital Management (HK) LTD | $14,105,453 | 177,897 | 0.13% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $13,252,259 | 176,485 | 0.12% | 주식 |
| ADAR1 Capital Management, LLC | $13,184,817 | 166,286 | 0.12% | 주식 |
| RHUMBLINE ADVISERS | $13,075,750 | 164,911 | 0.12% | 주식 |
| Sicart Associates LLC | $12,741,427 | 160,694 | 0.12% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $12,296,928 | 155,088 | 0.11% | 주식 |
| CSS LLC/IL | $12,074,995 | 152,289 | 0.11% | 주식 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $11,996,656 | 151,301 | 0.11% | 주식 |
| CITIGROUP INC | $11,996,577 | 151,300 | 0.11% | 콜 옵션 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11,893,500 | 150,000 | 0.11% | 주식 |
| Focus Partners Wealth | $11,728,366 | 147,917 | 0.11% | 주식 |
| Hudson Bay Capital Management LP | $11,497,050 | 145,000 | 0.11% | 주식 |
| Artia Global Partners LP | $11,447,573 | 144,376 | 0.11% | 주식 |
| Sonora Investment Management Group, LLC | $11,108,840 | 169,808 | 0.10% | 주식 |
| Fisher Asset Management, LLC | $10,877,317 | 137,184 | 0.10% | 주식 |
| Atle Fund Management AB | $10,873,116 | 137,131 | 0.10% | 주식 |
회사 내부자 48 명의 내부자 · 30 임원 · 19 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Brett P Monia | Chief Executive Officer | 2026년 6월 26일 M | 245,571 | 0 | 17 | $-42,648,430 |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2026년 3월 16일 M | 82,660 | 0 | 6 | $-21,117,075 |
| Kleanthis G Xanthopoulos | President of Regulus | 2007년 12월 3일 A | — | 0 | 0 | $0 |
| Holly B. Kordasiewicz | EVP, Chief Development Officer | 2026년 7월 7일 S | 22,096 | 0 | 4 | $-4,810,107 |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2026년 7월 7일 J | 0 | 0 | 14 | $-19,804,154 |
| Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 2026년 6월 26일 M | 77,114 | 0 | 6 | $-4,933,991 |
| Joseph Baroldi | EVP, Chief Business Officer | 2026년 6월 26일 M | 4,669 | 0 | 17 | $-6,405,525 |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2026년 6월 26일 S | 61,470 | 0 | 16 | $-16,034,086 |
| Eric Swayze | EVP Research | 2026년 6월 25일 S | 21,759 | 0 | 14 | $-8,058,784 |
| Brian Birchler | EVP, Corp and Development Ops | 2026년 4월 15일 M | 67,500 | 0 | 6 | $-3,556,351 |
| Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | 2026년 4월 15일 M | 23,713 | 0 | 4 | $-3,334,240 |
| Shannon L. Devers | EVP, Chief Human Resources Ofc | 2026년 4월 2일 S | 16,348 | 0 | 15 | $-8,854,430 |
| Richard S Geary | EVP, Chief Development Officer | 2025년 11월 6일 M | 59,657 | 0 | 13 | $-13,858,595 |
| Onaiza Cadoret-Manier | EVP,Chf GL Pdt Str & Oper Ofc | 2024년 2월 2일 S | 35,788 | 0 | 0 | $0 |
| Stanley T Crooke | Exec Chairman of the Board | 2021년 1월 26일 S | 2,021 | 0 | 0 | $0 |
| Damien Mcdevitt | Chief Business Officer | 2019년 7월 15일 M | 2,573 | 0 | 0 | $0 |
| Sarah Boyce | Chief Business Officer | 2018년 1월 15일 M | 8,931 | 0 | 0 | $0 |
| ECKER DAVID J | Vice President | 2008년 9월 2일 M | 0 | 0 | 0 | $0 |
| Michael J Treble | Vice President, Pres of Ibis | 2008년 8월 11일 M | 0 | 0 | 0 | $0 |
| Jeffrey M Jonas | Executive Vice President | 2008년 1월 2일 A | — | 0 | 0 | $0 |
| Mark K Wedel | VP & Chief Medical Officer | 2007년 7월 6일 M | 6,603 | 0 | 0 | $0 |
| LEVIN ARTHUR A | Vice President | 2007년 4월 25일 M | 1,674 | 0 | 0 | $0 |
| BROWN RICHARD K | Vice President | 2006년 3월 8일 M | 2,348 | 0 | 0 | $0 |
| MCNEIL JOHN A | Vice President | 2005년 1월 3일 A | — | 0 | 0 | $0 |
| LOWENSTAM PATRICIA | Vice President | 2005년 1월 3일 A | 603 | 0 | 0 | $0 |
| STEIN ARON | Vice President | 2004년 7월 1일 J | 1,536 | 0 | 0 | $0 |
| Hans A De Haan | VP, Drug Development | 2004년 4월 27일 S | 0 | 0 | 0 | $0 |
| LUNDSTEDT KAREN S | Vice President | 2004년 3월 10일 M | 5,407 | 0 | 0 | $0 |
| COLE DOUGLAS L | Vice President | 2004년 3월 9일 M | 9,616 | 0 | 0 | $0 |
| HOLMLUND JON T | Vice President | 2003년 7월 1일 J | 983 | 0 | 0 | $0 |
| Michael R Hayden | 이사 | 2026년 7월 31일 P | 24,000 | 2 | 0 | $1,058,700 |
| Peter N Reikes | 이사 | 2026년 7월 15일 A | 14,222 | 0 | 0 | $0 |
| Ludwig Hantson | 이사 | 2026년 7월 15일 A | — | 0 | 0 | $0 |
| Joan E Herman | 이사 | 2026년 7월 15일 M | 51,306 | 0 | 2 | $-3,173,720 |
| BERTHELSEN SPENCER R | 이사 | 2026년 7월 15일 M | 161,233 | 0 | 2 | $-1,193,280 |
| Allene M. Diaz | 이사 | 2026년 7월 7일 M | 3,811 | 0 | 5 | $-5,278,717 |
| Michael J. Yang | 이사 | 2026년 7월 1일 A | 7,940 | 0 | 0 | $0 |
| Joseph Loscalzo | 이사 | 2026년 7월 1일 A | 36,330 | 0 | 6 | $-8,047,872 |
| Joseph Klein III | 이사 | 2026년 7월 1일 A | 11,014 | 0 | 14 | $-9,356,036 |
| Lynne B Parshall | 이사 | 2026년 4월 15일 S | 51,344 | 0 | 6 | $-2,171,964 |
| Joseph H Wender | 이사 | 2025년 12월 1일 S | 36,035 | 0 | 13 | $-8,660,283 |
| MUTO FREDERICK T | 이사 | 2022년 7월 15일 M | 59,597 | 0 | 0 | $0 |
| Breaux Castleman | 이사 | 2020년 7월 1일 A | 19,183 | 0 | 0 | $0 |
| REED JOHN C | 이사 | 2012년 9월 6일 M | 0 | 0 | 0 | $0 |
| Richard D Dimarchi | 이사 | 2010년 7월 1일 A | — | 0 | 0 | $0 |
| GARIELI CHRISTOPHER | 이사 | 2005년 7월 1일 A | 155,431 | 0 | 0 | $0 |
| SKALETSKY MARK B | 이사 | 2004년 7월 1일 A | — | 0 | 0 | $0 |
| ISIS PHARMACEUTICALS INC | 10% 소유주 | 2020년 10월 10일 P | 98,322,397 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 5 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. (“Ionis”) ×8 제출 서류 | 2020년 10월 13일 | — | 최초 제출 | — | SEC |
| Isis Pharmaceuticals, Inc. (“ Isis ”) | 2015년 7월 31일 | — | 최초 제출 | — | SEC |
| Isis Pharmaceuticals, Inc. (“Isis”), Stanley T. Crooke (“Crooke”), B. Lynne Parshall (“Parshall”) ×2 제출 서류 | 2014년 11월 6일 | — | 최초 제출 | — | SEC |
| Genzyme Corporation | 2008년 1월 15일 | — | 최초 제출 | 수동적 투자 | SEC |
| 미공개 보고자 | 2001년 4월 12일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 85 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 1.74% | 288,230 NS | 2026년 4월 30일 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.72% | 201,598 NS | 2026년 4월 30일 | N-PORT |
| BBP · ETFis Series Trust I | 1.48% | 11,708 NS | 2026년 4월 30일 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1.37% | 3,614 NS | 2026년 5월 31일 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 1.14% | 414,653 NS | 2026년 5월 31일 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.94% | 64,911 NS | 2026년 4월 30일 | N-PORT |
| NUSC · Nushares ETF Trust | 0.87% | 150,398 NS | 2026년 4월 30일 | N-PORT |
| TAX · EA Series Trust | 0.87% | 2,885 NS | 2026년 5월 29일 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0.84% | 1,257 NS | 2026년 4월 30일 | N-PORT |
| COPY · RBB Fund Trust | 0.84% | 37,653 NS | 2026년 5월 31일 | N-PORT |
| HRTS · Tema ETF Trust | 0.83% | 5,599 NS | 2026년 5월 31일 | N-PORT |
| IBB · iShares Trust | 0.68% | 1,189,984 SH | 2026년 8월 8일 | 일간 |
| FFND · Northern Lights Fund Trust II | 0.67% | 9,000 NS | 2026년 5월 31일 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.64% | 8,994 SH | 2026년 8월 8일 | 일간 |
| BIB · ProShares Trust | 0.63% | 6,109 NS | 2026년 5월 31일 | N-PORT |
| MEDI · Harbor ETF Trust | 0.58% | 2,153 NS | 2026년 4월 30일 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0.53% | 60,169 NS | 2026년 4월 30일 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.53% | 36,525 NS | 2026년 4월 30일 | N-PORT |
| OASC · Unified Series Trust | 0.47% | 5,182 NS | 2026년 5월 31일 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0.45% | 94,260 SH | 2026년 8월 8일 | 일간 |
| CGGR · Capital Group Growth ETF | 0.36% | 1,150,284 NS | 2026년 5월 31일 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.34% | 2,078,639 SH | 2026년 8월 8일 | 일간 |
| SMMV · iShares Trust | 0.32% | 17,089 SH | 2026년 8월 8일 | 일간 |
| BKMC · BNY Mellon ETF Trust | 0.30% | 25,160 NS | 2026년 4월 30일 | N-PORT |
| ISCG · iShares Trust | 0.28% | 51,765 SH | 2026년 8월 8일 | 일간 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.26% | 778,644 NS | 2026년 5월 31일 | N-PORT |
| IWP · iShares Trust | 0.24% | 895,755 SH | 2026년 8월 8일 | 일간 |
| SCHM · SCHWAB STRATEGIC TRUST | 0.23% | 438,447 NS | 2026년 5월 31일 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.23% | 71,810 NS | 2026년 4월 30일 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.22% | 60,227 NS | 2026년 4월 30일 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.22% | 110,695 SH | 2026년 8월 8일 | 일간 |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.21% | 62,392 NS | 2026년 4월 30일 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0.21% | 16,403 NS | 2026년 4월 30일 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.20% | 36,263 NS | 2026년 4월 30일 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.20% | 50,927 SH | 2026년 8월 8일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.19% | 70,978 NS | 2026년 4월 30일 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.18% | 471,609 SH | 2026년 8월 8일 | 일간 |
| SMLF · iShares Trust | 0.17% | 133,297 SH | 2026년 8월 8일 | 일간 |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.16% | 10,044 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.15% | 1,895,610 SH | 2026년 8월 8일 | 일간 |
| VB · VANGUARD INDEX FUNDS | 0.15% | 3,600,281 SH | 2026년 8월 8일 | 일간 |
| ESML · iShares Trust | 0.15% | 78,764 SH | 2026년 8월 8일 | 일간 |
| IYH · iShares Trust | 0.15% | 98,412 SH | 2026년 8월 8일 | 일간 |
| NBCR · Neuberger Berman ETF Trust | 0.14% | 16,581 NS | 2026년 5월 31일 | N-PORT |
| ISCB · iShares Trust | 0.14% | 7,328 SH | 2026년 8월 8일 | 일간 |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.13% | 176 NS | 2026년 5월 31일 | N-PORT |
| SMMD · iShares Trust | 0.12% | 81,988 SH | 2026년 8월 8일 | 일간 |
| WSML · iShares Trust | 0.08% | 9,548 SH | 2026년 8월 8일 | 일간 |
| LRND · New York Life Investments ETF Trust | 0.07% | 2,788 NS | 2026년 4월 30일 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.07% | 9,928 SH | 2026년 8월 8일 | 일간 |